XML 41 R24.htm IDEA: XBRL DOCUMENT
v3.25.1

Share Based Awards | 3 Months Ended
--- | ---
Mar. 31, 2025
Share-Based Payment Arrangement [Abstract] |
Share Based Awards | Note 16 – Share Based Awards The 2019 Equity Incentive Plan (the “2019 Plan”) and the 2024 Omnibus Equity Incentive Plan (the “2024 Plan”) (collectively, the “Plans”) allow us to incentivize key employees, consultants, and directors with long term compensation awards such as stock options, restricted stock, and restricted stock units (collectively, the “Awards”). The number of shares issuable in connection with Awards under the 2019 Plan were not to exceed 11,750,000. However, no shares are issuable under the 2019 Plan after the 2024 Plan became effective on October 15, 2024. The number of shares issuable in connection with Awards under the 2024 Plan may not exceed 11,250,000 plus any underlying forfeited 2019 Plan awards.
| A. | Options
The range of assumptions used to calculate the fair value of options granted during the three months ended March 31, 2025 was: Schedule of Assumptions Used to Calculate the Fair Value of Options Granted
Exercise Price |  |  | $ 8.56 – 8.56 |
Stock price on date of grant |  |  | 8.46 – 8.46 |
Risk-free interest rate |  |  | 4.44 – 4.44 | %
Dividend yield |  |  | — |
Expected term (years) |  |  | 5.97 – 5.97 |
Volatility |  |  | 191.15 – 191.15 | %
A summary of options activity under the Plan since December 31, 2024 was: Schedule of Options Activity
|  | Shares |  |  | Weighted- Average Exercise Price |  |  | Weighted- Average Remaining Contractual Term |  |  | Aggregate Intrinsic Value |
Outstanding as of December 31, 2024 |  |  | 5,645,325 |  |  |  | 1.54 |  |  |  | 7.90 |  |  |  | 59,779,836 |
Granted |  |  | 402,500 |  |  |  | 8.56 |  |  |  |  |  |  |  |  |
Exercised |  |  | (908,503 | ) |  |  | 1.28 |  |  |  |  |  |  |  |  |
Forfeited or expired |  |  | (127,502 | ) |  |  | 1.73 |  |  |  |  |  |  |  |  |
Outstanding as of March 31, 2025 |  |  | 5,011,820 |  |  |  | 2.06 |  |  |  | 1.99 |  |  |  | 20,221,803 |
Exercisable as of March 31, 2025 |  |  | 1,633,529 |  |  | $ | 1.47 |  |  |  | 1.35 |  |  | $ | 7,200,542 |
The aggregate intrinsic value of outstanding options represents the excess of the stock price at the indicated date over the exercise price of each option. As of March 31, 2025, there was $6,622,720 of unrecognized stock-based compensation expense related to unvested stock options which is expected to be recognized over the weighted average periods of 1.49 years. As of December 31, 2024, there was $4,068,622 of unrecognized stock-based compensation expense related to unvested stock options which is expected to be recognized over the weighted average periods of 1.25 years.
| B. | Restricted Stock
A summary of restricted stock activity under the Plan since December 31, 2024 was: Schedule of Restricted Stock Activity
|  | Shares |  |  | Weighted Average Grant-Date Fair Value Per Share |
Unvested and outstanding as of December 31, 2024 |  |  | 1,544,027 |  |  | $ | 3.84 |
Granted |  |  | 50,000 |  |  |  | 4.94 |
Vested |  |  | — |  |  |  | — |
Forfeited |  |  | (321,428 | ) |  |  | 0.89 |
Unvested and outstanding as of March 31, 2025 |  |  | 1,272,599 |  |  | $ | 4.64 |
As of March 31, 2025, there was $4,497,389 of unrecognized stock-based compensation expense related to unvested restricted stock units which is expected to be recognized over the weighted average periods of 1.13 years. As of December 31, 2024, $5,328,970 of unrecognized stock-based compensation expense related to unvested restricted stock units which is expected to be recognized over the weighted average periods of 1.25 years.
| C. | Stock Compensation
Stock compensation expense for the three months ended March 31 by functional operating expense was: Schedule of Stock Compensation Expense by Functional Operating Expense
|  | 2025 |  |  | 2024 |
Research and development |  | $ | 174,460 |  |  | $ | 115,477 |
Sales and marketing |  |  | 862,983 |  |  |  | 85,205 |
General and administrative |  |  | 561,529 |  |  |  | 604,952 |
Total |  | $ | 1,598,972 |  |  | $ | 805,634 |
Stock compensation expense pertaining to options totaled $804,855 for the three months ended March 31, 2025. Stock compensation expense pertaining to restricted stock totaled $794,117 for the three months ended March 31, 2025. Stock compensation expense pertaining to options totaled $708,726 for the three months ended March 31, 2024. Stock compensation expense pertaining to restricted stock totaled $96,908 for the three months ended March 31, 2024.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/718/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (l) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration